Premium
HealthEquity Inc (HQY)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -3,14k | 298,49k | Automatic Disposition | 95,00 | 2,47k | -55,99% |
| 2026-05-28 | Ms. Gayle Furgurson WellbornIndependent Director | -2,44k | 104,36k | Derivative Exercise and Sale | 47,21 - 90,00 | 17,73k | - |
| 2026-05-28 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -7,50k | 675,00k | Automatic Disposition | 90,00 | 55,93k | -11,82% |
| 2026-04-06 | Dr. Stephen D. NeelemanFounder & Vice Chair | -2,56k | 214,54k | Sale to Issuer | 83,84 | 855,68k | -0,30% |
| 2026-04-06 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -2,48k | 208,00k | Sale to Issuer | 83,84 | 63,43k | -3,76% |
| 2026-04-06 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -3,38k | 283,20k | Sale to Issuer | 83,84 | 5,61k | -37,58% |
| 2026-04-06 | Mr. Elimelech RosnerInitié | -4,77k | 399,73k | Sale to Issuer | 83,84 | - | - |
| 2026-04-06 | Mr. James M. LucaniaCFO & Exec. VP | -4,39k | 368,29k | Sale to Issuer | 83,84 | 30,07k | -12,75% |
| 2026-04-06 | Mr. Scott R. CutlerCEO, President & Director | -4,93k | 413,40k | Sale to Issuer | 83,84 | 19,59k | -20,11% |
| 2026-03-31 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -7,73k | 637,60k | Sale to Issuer | 82,53 | - | - |
| 2026-03-31 | Dr. Stephen D. NeelemanFounder & Vice Chair | -9,29k | 766,84k | Sale to Issuer | 82,53 | 858,24k | -1,07% |
| 2026-03-31 | Mr. Elimelech RosnerInitié | -18,01k | 1,49M | Sale to Issuer | 82,53 | - | - |
| 2026-01-12 | Mr. Scott R. CutlerCEO, President & Director | -12,50k | 1,12M | Sale to Issuer | 89,83 | 13,25k | -48,53% |
| 2026-01-09 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -1,74k | 166,09k | Sale to Issuer | 95,24 | 48,05k | -3,50% |
| 2026-01-09 | Mr. James M. LucaniaCFO & Exec. VP | -2,47k | 235,23k | Sale to Issuer | 95,24 | 24,11k | -9,29% |
| 2026-01-09 | Mr. Elimelech RosnerInitié | -2,07k | 197,52k | Sale to Issuer | 95,24 | - | - |
| 2026-01-09 | Dr. Stephen D. NeelemanFounder & Vice Chair | -791,00 | 75,33k | Sale to Issuer | 95,24 | 837,83k | -0,09% |
| 2026-01-09 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -739,00 | 70,38k | Sale to Issuer | 95,24 | 47,52k | -1,53% |
| 2025-12-19 | Dr. Stephen D. NeelemanFounder & Vice Chair | -140,00k | 0,00 | Other Disposition | - | 836,30k | -14,34% |
| 2025-12-19 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -1,50k | 142,08k | Automatic Disposition | 94,72 | 46,11k | -3,15% |
| 2025-12-18 | Mr. Elimelech RosnerInitié | -10,96k | 1,05M | Vente | 95,45 | - | - |
| 2025-12-17 | Dr. Stephen D. NeelemanFounder & Vice Chair | -500,00 | 0,00 | Other Disposition | - | 836,30k | -0,06% |
| 2025-12-12 | Ms. Gayle Furgurson WellbornIndependent Director | -4,34k | 206,60k | Derivative Exercise and Sale | 50,41 - 98,03 | 17,73k | - |
| 2025-11-20 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -1,50k | 156,84k | Automatic Disposition | 104,56 | 47,61k | -3,05% |
| 2025-10-20 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -1,50k | 138,11k | Automatic Disposition | 92,07 | 49,12k | -2,96% |
| 2025-10-06 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -977,00 | 86,53k | Sale to Issuer | 88,57 | 50,62k | -1,89% |
| 2025-10-06 | Mr. James M. LucaniaCFO & Exec. VP | -2,39k | 211,94k | Sale to Issuer | 88,57 | 21,15k | -10,16% |
| 2025-10-06 | Dr. Stephen D. NeelemanFounder & Vice Chair | -1,06k | 93,70k | Sale to Issuer | 88,57 | 836,80k | -0,13% |
| 2025-10-07 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -1,78k | 157,10k | Automatic Disposition | 88,21 | 49,80k | -3,45% |
| 2025-10-06 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -1,65k | 146,05k | Sale to Issuer | 88,57 | 49,80k | -3,21% |
| 2025-10-06 | Mr. Elimelech RosnerInitié | -3,01k | 266,23k | Sale to Issuer | 88,57 | - | - |
| 2025-09-19 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -6,00k | 564,65k | Automatic Disposition | 93,91 - 95,70 | 49,45k | -10,82% |
| 2025-09-05 | Ms. Evelyn S. DilsaverIndependent Director | 11,54k | 245,43k | Derivative Exercise and Retained Stock | 21,27 | 46,21k | 33,29% |
| 2025-09-05 | Ms. Evelyn S. DilsaverIndependent Director | -3,46k | 249,30k | Derivative Exercise and Sale | 21,27 - 93,30 | 46,21k | - |
| 2025-07-28 | Dr. Stephen D. NeelemanFounder & Vice Chair | -3,00k | 0,00 | Other Disposition | - | 835,54k | -0,36% |
| 2025-07-03 | Mr. Delano LaddExec. VP, General Counsel & Secretary | -970,00 | 97,85k | Sale to Issuer | 100,87 | 55,45k | -1,72% |
| 2025-07-03 | Mr. James M. LucaniaCFO & Exec. VP | -2,38k | 239,57k | Sale to Issuer | 100,87 | 18,12k | -11,59% |
| 2025-07-03 | Dr. Stephen D. NeelemanFounder & Vice Chair | -1,05k | 105,81k | Sale to Issuer | 100,87 | 838,54k | -0,12% |
| 2025-07-03 | Mr. Elimelech RosnerInitié | -2,98k | 300,80k | Sale to Issuer | 100,87 | - | - |
| 2025-07-07 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -1,79k | 182,50k | Automatic Disposition | 101,50 - 102,09 | 53,23k | -3,26% |
| 2025-07-03 | Mr. Michael FioreExec. VP & Chief Commercial Officer | -1,64k | 165,03k | Sale to Issuer | 100,87 | 53,23k | -2,98% |
| 2025-06-06 | Mr. Jon KesslerInitié | -151,21k | 8,06M | Derivative Exercise and Sale | 41,28 - 112,39 | 328,51k | - |
| 2025-06-06 | Mr. Jon KesslerInitié | -80,74k | 9,06M | Vente | 111,98 - 113,35 | 328,51k | -19,73% |
| 2025-06-06 | Mr. Elimelech RosnerInitié | -71,00k | 7,98M | Vente | 111,37 - 112,56 | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
